However, in Asian patients with longstanding type 2 diabetes, a therapy with premixed insulin following continuous subcutaneous insulin infusion (CSII) therapy was related to a higher risk of hypoglycaemia in normal-weight men [118]. The gene discussed is INS; the disease is Hypoglycemia.